Drug Shortage Report for ENABLEX

Last updated on 2018-12-15 History
Report ID 61675
Drug Identification Number 02273225
Brand name ENABLEX
Common or Proper name darifenacin
Company Name SEARCHLIGHT PHARMA INC
Market Status MARKETED
Active Ingredient(s) DARIFENACIN
Strength(s) 15MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size Bottles of 100
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-09-17
Estimated end date 2018-12-14
Actual end date 2018-12-14
Shortage status Resolved
Updated date 2018-12-15
Company comments Reason for Shortage: Production Delay. For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com or by fax at 1-519-751-9149.
Health Canada comments
Tier 3 Status No
Contact Address 1600 RUE NOTRE DAME OUEST, SUITE 312
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-09-17 English Compare
v2 2018-09-17 English Compare
v3 2018-09-17 English Compare
v4 2018-09-17 English Compare
v5 2018-09-17 French Compare
v6 2018-09-17 French Compare
v7 2018-09-17 English Compare
v8 2018-09-17 French Compare
v9 2018-09-17 French Compare
v10 2018-09-18 English Compare
v11 2018-11-14 English Compare
v12 2018-11-14 French Compare
v13 2018-11-22 English Compare
v14 2018-11-22 French Compare
v15 2018-12-04 English Compare
v16 2018-12-04 French Compare
v17 2018-12-11 English Compare
v18 2018-12-11 French Compare
v19 2018-12-11 English Compare
v20 2018-12-11 French Compare

Showing 1 to 20 of 23